The concept of continuous low-dose ("metronomic") antiangiogenic chemotherapy.

被引：0
|
作者：
Klement, G
Kerbel, R
机构：
[1] Sunnybrook & Womens Coll, Ctr Hlth Sci, Toronto, ON, Canada
[2] Univ Toronto, Toronto, ON, Canada
来源：
CLINICAL CANCER RESEARCH | 2000年 / 6卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
048
引用
收藏
页码：4483S / 4483S
页数：1
相关论文
共 50 条
  • [1] Optimal low-dose metronomic chemotherapy and antiangiogenic activity
    Ruth Kirby
    Nature Clinical Practice Oncology, 2005, 2 (10): : 489 - 489
  • [2] Thrombospondin 1, a mediator of the antiangiogenic effects of low-dose metronomic chemotherapy
    Bocci, G
    Francia, G
    Man, S
    Lawler, J
    Kerbel, RS
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (22) : 12917 - 12922
  • [3] CONTINUOUS LOW-DOSE (METRONOMIC) ORAL CHEMOTHERAPY OF CANINE APPENDICULAR OSTEOSARCOMA
    Woods, J. P.
    Boston, S.
    Mutsaers, A. J.
    Saam, D. E.
    Coomber, B.
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2012, 26 (03) : 815 - 815
  • [4] Low-dose metronomic chemotherapy: Myth or truth?
    Baruchel, Sylvain
    Stempak, Diana
    ONKOLOGIE, 2006, 29 (07): : 305 - 307
  • [5] Low-dose metronomic chemotherapy: A systematic literature analysis
    Lien, K.
    Georgsdottir, S.
    Sivanathan, L.
    Chan, K.
    Emmenegger, U.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 (16) : 3387 - 3395
  • [6] Low-dose metronomic cisplatin as an antiangiogenic and anti-inflammatory strategy for cancer
    Kikuchi, Hiroshi
    Maishi, Nako
    Yu, Li
    Jia, Zi
    Li, Cong
    Sato, Masumi
    Takeda, Ryo
    Ishizuka, Keita
    Hida, Yasuhiro
    Shinohara, Nobuo
    Hida, Kyoko
    BRITISH JOURNAL OF CANCER, 2024, 130 (02) : 336 - 345
  • [7] Low-dose metronomic cisplatin as an antiangiogenic and anti-inflammatory strategy for cancer
    Hiroshi Kikuchi
    Nako Maishi
    Li Yu
    Zi Jia
    Cong Li
    Masumi Sato
    Ryo Takeda
    Keita Ishizuka
    Yasuhiro Hida
    Nobuo Shinohara
    Kyoko Hida
    British Journal of Cancer, 2024, 130 : 336 - 345
  • [8] A mathematical model to study low-dose metronomic scheduling for chemotherapy
    Arora, Garhima
    Bairagi, Nandadulal
    Chatterjee, Samrat
    MATHEMATICAL BIOSCIENCES, 2024, 372
  • [9] Antiangiogenic metronomic chemotherapy
    Sarmiento, Roberta
    Gasparini, Giampietro
    ONKOLOGIE, 2008, 31 (04): : 161 - 162
  • [10] Metronomic low-dose chemotherapy boosts CD95-dependent antiangiogenic effect of the thrombospondin peptide ABT-510: A complementation antiangiogenic strategy
    Yap, R
    Veliceasa, D
    Emmenegger, U
    Kerbel, RS
    McKay, LM
    Henkin, J
    Volpert, OV
    CLINICAL CANCER RESEARCH, 2005, 11 (18) : 6678 - 6685
12345